Introduction {#Sec1}
============

Symptomatic hypocalcemia occurs with decreased levels of circulating ionized calcium. In general, half of the total circulating calcium is ionized with 40% bound to plasma proteins, primarily albumin, and 10% to anions such as sulfate, citrate, and phosphate \[[@CR1]\]. Total calcium is often used as a surrogate for ionized calcium, adjusting for hypoalbuminemia. The adjusted calcium formula may not adequately reflect ionized calcium concentrations, however, and is not a reliable substitute in critically ill trauma patients \[[@CR2]--[@CR6]\]. While reference ranges vary by institution, cited lower limit of normal ionized calcium ranges between 4 mg/dL (1 mmol/dL) and 4.8 mg/dL (1.2 mmol/dL) \[[@CR7]\] Hypocalcemia as a result of transfusion is posited to occur via the citrate anticoagulant contained in stored blood. The transfused citrate binds ionized calcium in the recipient, and the resultant hypocalcemia is thought to be most prominent after the transfusion of plasma and platelets, due to their high citrate concentration. More than 90% of the citrate present in an original blood donation bag is found in plasma and platelets, since citrate partitions with plasma and is separated from the pRBCs during component separation \[[@CR8]\]. Hypocalcemia is typically transient in standard transfusion because citrate undergoes rapid hepatic metabolism. The healthy adult liver metabolizes 3 grams of citrate per 1 unit of blood administered every 5 min \[[@CR9]\]. Massive transfusion may result in a large influx of citrate, amplified by an impairment in citrate metabolism due to hypothermia, hypoperfusion and liver dysfunction \[[@CR10]--[@CR12]\]. Patients with citrate toxicity resulting in hypocalcemia may present with prolonged QT on EKG, tetany, decreased myocardial contractility, refractory hypotension, or arrhythmia \[[@CR10], [@CR12], [@CR13]\]. While hypocalcemia is often cited as a sequelae of transfusion of blood products, there are limited studies that examine hypocalcemia and its relationship to blood transfusion as a primary outcome.

The primary objective of this study was to determine if the transfusion of pRBC is an independent predictor of hypocalcemia in trauma patients. The second objective was to determine if ionized calcium decreased in a dose-dependent relationship with transfusion of pRBC. We hypothesized that pRBC administration was an independent predictor of hypocalcemia.

Methods {#Sec2}
=======

This was a retrospective single-center study including all trauma patients ≥ 18 yo presenting to the emergency department (ED) that had an ionized calcium level drawn within 48 h of arrival within a decade.

After Institutional Review Board (IRB) approval was obtained, the Los Angeles County + University of Southern California electronic medical records was queried for all trauma patients with a total calcium or ionized calcium (iCa) drawn within 48 h of admission (01/2004--12/2014). Our institution reference for ionized calcium is 4.5 mg/dL--5.3 g/dL with a critical low trigger of 3.6 mg/dL, similar to previously cited articles of symptomatic hypocalcemia. These patients were cross-referenced with the Trauma Registry and all patients less than 18 years were excluded. For all patients included in this study criteria, age, sex, race, mechanism of injury, systolic blood pressure (SBP), heart rate, Glasgow Coma Scale (GCS) score, Injury Severity Score (ISS), AIS by body region, blood product requirements, interventions, discharge capacity, discharge disposition, ventilator days, hospital length of stay (LOS), ICU LOS, and in-hospital mortality were abstracted. All iCa values for each patient and the time of the iCa sample collection were collected and analyzed. First, minimum iCa and last iCa along with time drawn after admission were calculated. An iCa ≤ 3.6 mg/dL was defined as severe hypocalcemia, as previously described in the literature.

Descriptive statistics were calculated for all variables. Independent *t* test was used for normally distributed continuous data, which were reported as mean ± SD. Mann--Whitney *U* was used for not normally distributed ordinal and continuous data and reported as median (intraquartile range). Pearson's Chi-squared test or Fisher's exact test were used for categorical data and were reported as percentages. Univariate analysis was used to identify variables predictive of hypocalcemia. Independent variables with *p* values \< 0.2 and variables of known clinical significance were further analyzed with multivariable analysis. Potential predictors were assessed in a backwards stepwise fashion, and retained for statistical significance or for a greater than 15% change in the severe hypocalcemia effect estimate. Transfused blood products were maintained as continuous variables in the regression model. Multivariable regression was similarly performed for mortality and for the effect of combined pRBC + FFP administration of 4 units on mortality. Potential effect modification was evaluated by testing for significant interactions between variables. *P* values \< 0.05 were considered statistically significant. Area Under the Receiving Operator Characteristic (AUROC) was used to assess discriminative power of the regression model. Adjusted odds ratio (AOR) with 95% confidence interval (CI) was derived from the logistic regression. Statistical analysis was performed using SPSS for Mac, version 23 (IBM Corporation, Armonk, NY) and R version 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria).

Results {#Sec3}
=======

Of the 45,996 trauma patients admitted during the 11-year study period, 7341 (16.0%) were adult patients with iCa drawn within the first 48 h. Of these patients meeting inclusion criteria, 716 (9.8%) developed severe hypocalcemia within 48 h of admission. The study population was predominantly male (81.2%), with a median age 39 (Range: 18--102) years, SBP 131 (IQR: 114--150), median GCS 15 (IQR: 10--15), ISS 14 (IQR: 9--25). The most common mechanism of injury was fall (20.2%) followed by motor vehicle collision (18.9%).

Median mininum ionized calcium was 3.1 (2.5--3.4) in the severe hypocalcemia group and 4.4 ± (4.1--4.7) in the non-severe hypocalcemic group. Severe hypocalcemia patients were more likely to have a depressed GCS 13 (3 vs 15, *p* \< 0.0001), hypotension (23.2% vs 5.1%) and tachycardia (57% vs 41.9%, *p* \< 0.0001) when compared to non-hypocalcemia patients. The Maximum Abbreviated Injury Scale (AIS) for Head, Chest, Abdomen/Pelvis, Extremities, and External were all greater in hypocalcemic patients (Table [1](#Tab1){ref-type="table"}). Severe hypocalcemic patients had higher rates of intubation (47.1% vs 28.4%, *p* \< 0.0001) and higher emergency operation rates (71.8% vs 29.0%, *p* \< 0.0001).Table 1Demographics of Trauma Patients with Severe Hypocalcemia compared to No Severe Hypocalcemia from January 2004 to December 2014 (*n* = 7341)VariableTotal, *n* = 7341Severe hypocalcemia, *n* = 716No severe hypocalcemia, *n* = 6625*P* valueAge, years, median (IQR)39.0 (26--55)33.0 (24--50)40.0 (26--56)\<0.0001Male gender, *n* (%)5960 (81.2)581 (81.1)5379 (81.2)0.9690Race, *n* (%)73417166625\<0.0001 Hispanic4182 (57.0)429 (59.9)3753 (56.6) White1596 (21.7)123 (17.2)1473 (22.2) Asian725 (9.9)73 (10.2)652 (9.8) Black597 (8.1)71 (9.9)526 (7.9) Other194 (2.6)17 (2.4)177 (2.7) Unknown47 (0.6)3 (0.4)44 (0.7)Weight, kg, mean ± SD77.1 ± 11.876.0 ± 9.877.1 ± 120.8320Mechanism, *n* (%)73417166625\<0.0001Blunt4966 (67.6)367 (51.3)4599 (69.4) Fall1484 (20.2)53 (7.4)1431 (21.6) MVC1391 (18.9)100 (14.0)1291 (19.5) AVP/AVB1121 (15.3)139 (19.4)982 (14.8) Assault423 (5.8)18 (2.5)405 (6.1) MCC384 (5.2)42 (5.9)342 (5.2) Fall \> 15 ft163 (2.2)15 (2.1)148 (2.2)Penetrating1740 (23.7)312 (43.6)1428 (21.6) GSW1132 (15.4)224 (31.3)908 (13.7) SW608 (8.3)88 (12.3)520 (7.8) Other435 (5.9)27 (3.8)408 (6.2) Unknown200 (2.7)10 (1.4)190 (2.9)ISS, median (IQR)14 (9--25)25 (14--34)14 (9--22)\<0.0001Admission GCS, median (IQR)15 (10--15)13 (3--15)15 (11--15)\<0.0001GCS ≤ 8, *n* (%)1525 (20.8)277 (38.7)1248 (18.8)\<0.0001Admission SBP, median (IQR)131 (114--150)118 (90--138)133 (115--151)\<0.0001Hypotension, SBP \< 90, *n* (%)501 (6.8)166 (23.2)335 (5.1)\<0.0001Admission HR, median (IQR)95 (80--113)106 (82--129)95 (80--112)\<0.0001Tachycardia, HR ≥ 100, *n* (%)3186 (43.4)408 (57.0)2778 (41.9)\<0.0001Maximum AIS head, median (IQR)0 (0--3)0 (0--4)0 (0--3)0.7960Maximum AIS face, median (IQR)0 (0--0)0 (0--0)0 (0--0)0.2290Maximum AIS chest, median (IQR)0 (0--3)2 (0--3)0 (0--2)\<0.0001Maximum AIS abdomen/pelvis, median (IQR)0 (0--2)2(0--3)0(0--2)\<0.0001Maximum AIS extremities, median (IQR)0 (0--3)0(0--3)0(0--3)0.0180Maximum AIS external, median (IQR)1 (0--1)1(0--1)1(0--1)\<0.0001Severe hypocalcemia defined as ionized calcium less than 0.9 mmol/dL or 3.6 mg/dL within 48 h of admission*MVC* motor vehicle collision, *AVP* automobile versus pedestrian, *AVB* automobile versus bicycle, *MCC* motorcycle collision, *GSW* gunshot wound, *SW* stab wound, *ISS* injury severity score, *GCS* glasgow coma scale, *SBP* systolic blood pressure, *HR* heart rate, *AIS* abbreviated injury scale

Patients that ultimately developed severe hypocalcemia were administered more blood products prior to minimum iCa drawn \[pRBC (8 vs 0, *p* \< 0.0001), plasma (4 vs 0, *p* \< 0.0001), and platelets (0 vs 0, *p* \< 0.0001)\]. They also received more blood products within 24 h of admission \[24-h pRBC (11 vs 0, *p* \< 0.0001), 24-h plasma (8 vs 0, *p* \< 0.0001), 24-h platelet (1 vs 0, *p* \< 0.0001)\] as well as during their total hospital length of stay. Overall, 38.8% of patients received a blood transfusion prior to the iCa nadir with a higher percent of patients in the hypocalcemia group receiving blood (94.7% vs 32.9%, *p* \< 0.0001). Overall, 9.1% of patients received a massive transfusion defined as 10 or more units of pRBC within 24 h of admission. This was higher in the hypocalcemia group (59.4% vs 3.7%, *p* \< 0.0001). Mean last ionized calcium within 48 h of admission was 4.5 (4.0--4.8) in the severe hypocalcemic group compared to 4.7 (4.5--4.8) in the non-severe hypocalcemic group (*p* \< 0.001) (Table [2](#Tab2){ref-type="table"}).Table 2Interventions of trauma patients with severe hypocalcemia compared to no severe hypocalcemia from January 2004 to December 2014 (*n* = 7341)VariableTotal, *n* = 7341Severe hypocalcemia, *n* = 716No severe hypocalcemia, *n* = 6625*P* valueIntubated, *n* (%)2211 (30.3)337 (47.1)1874 (28.4)\<0.0001Intravenous fluids, median (IQR)1000 (860--2000)1000 (1000--2000)1000 (800--2000)0.0420Next Phase After ED, *n* (%)73417166625\<0.0001 ICU2899 (39.5)160 (22.3)2739 (41.3) OR2432 (33.1)514 (71.8)1918 (29.0) Ward1799 (24.5)34 (4.7)1765 (26.6) Stepdown107 (1.5)2 (0.3)105 (1.6) Unknown89 (1.2)4 (0.6)85 (1.3) Other15 (0.2)2 (0.3)13 (0.2)pRBC, unit, median (IQR) Prior to min iCa0 (0--2)8 (4--15)0 (0--2)\<0.0001 Total, first 24 h0 (0--3)11 (6--21)0 (0--2)\<0.0001 Total, length of stay1 (0--4)14 (8--25)0 (0--4)\<0.0001FFP, unit, median (IQR) Prior to min iCa0 (0--0)4 (2--8)0 (0--0)\<0.0001 Total, first 24 h0 (0--2)8 (4--14)0 (0--0)\<0.0001 Total, length of stay0 (0--2)9 (4--18)0 (0--2)\<0.0001Platelet, unit, median (IQR) Prior to min iCa0 (0--0)0 (0--2)0 (0--0)\<0.0001 Total, first 24 h0 (0--0)1 (0--3)0 (0--0)\<0.0001 Total, length of stay0 (0--0)2 (0--4)0 (0--2)\<0.0001Cryoprecipitate, unit, median (IQR) Prior to min iCa0 (0--0)0 (0--0)0 (0--0)\<0.0001 Total, first 24 h0 (0--0)0 (0--0)0 (0--0)\<0.0001 Total, length of stay0 (0--0)0 (0--0)0 (0--0)\<0.0001Transfusion given in first 24 h, *n* (%)2849 (38.8)678 (94.7)2178 (32.9)\<0.0001Factor VII given in first 24 h, *n* (%)153 (2.1)104 (14.5)49 (0.7)\<0.0001Massive transfusion patient, *n* (%)667 (9.1)425 (59.4)242 (3.7)\<0.0001First iCa, median (IQR)4 (3.9--4.6)4 (3.4--4.4)4.4 (4.0--4.7)\<0.0001Minimum iCa first 48 h, median (IQR)4.4 (4.0--4.6)3.1 (2.5--3.4)4.4 (4.1--4.7)\<0.0001Maximum iCa in first 48 h, median (IQR)4.8 (4.6--5.0)4.8 (4.5--5.1)4.8 (4.6--4.9)0.3760Last iCa in first 48 h, median (IQR)4.7 (4.4--4.8)4.5 (4.0--4.8)4.7 (4.5--4.8)\<0.0001Time to min iCa, minutes, median (IQR)338.0 (149--955.5)185.0 (108--339)408.5 (169--1114)Time to max iCa, minutes, median (IQR)706.0 (224--1743.5)453.0 (154.--1293)776.5 (249--1815.5)\<0.0001Intervention in 48 h, *n* (%)73417166625\<0.0001 None5117 (69.7)298 (41.6)4819 (72.7) OR2195 (29.9)408 (57.0)1787 (27.0) IR16 (0.2)2 (0.3)14 (0.2) Both13 (0.2)8 (1.1)5 (0.1)Severe hypocalcemia defined as ionized calcium less than 0.9 mmol/dL or 3.6 mg/dL within 48 h of admissionMassive transfusion defined as 10 unit pRBC or more in 24 h*ED* Emergency Department, *ICU* intensive care unit, *OR* operating room, *pPRBC* packed red blood cells, *min* minimum, *iCa* ionized calcium, *FFP* fresh frozen plasma, *max* maximum, *IR* interventional radiology

Only 34.6% severe hypocalcemic patients went home at discharge compared to 54.1% of non-severe hypocalcemic patients. Hypocalcemic patients had longer hospital LOS (9 vs 7 days, *p* \< 0.0001), more frequently required ICU support (79.7% vs 74.2%, *p* \< 0.0001), had a longer ICU LOS (4 vs 3 days, *p* \< 0.0001), and had a higher mortality (37.7% vs 10.1%, *p* \< 0.0001) (Table [3](#Tab3){ref-type="table"}).Table 3Outcomes of trauma patients with severe hypocalcemia compared to no severe hypocalcemia from January 2004 to December 2014 (*n* = 7341)VariableTotal, *n* = 7341Severe hypocalcemia, *n* = 716No severe hypocalcemia, *n* = 6625*P* valueDischarge capacity, *n* (%)73417166625 Temporary disability, \< 1 year6119 (83.4)410 (57.3)5709 (86.2)\<0.0001 Deceased or unknown990 (13.5)273 (38.1)717 (10.8) Disabled204 (2.8)31 (4.3)173 (2.6) Pre--injury capacity28 (0.4)2 (0.3)26 (0.4)Discharge disposition, *n* (%)73417166625\<0.0001 Home3835 (52.2)248 (34.6)3587 (54.1) Transfer to OSH1106 (15.1)92 (12.8)1014 (15.3) Expired932 (12.7)270 (37.7)662 (10.0) SNF/rehab783 (10.7)62 (8.7)721 (10.9) Other685 (9.3)44 (6.1)641 (9.7)Required ICU, *n* (%)5486 (74.7)571 (79.7)4915 (74.2)0.0010Hospital LOS, median (IQR)7 (4--17)9 (1--26)7 (4--16)0.5260Ventilator days, median (IQR)0 (0--2)0 (0--4)0 (0--2)0.0110ICU LOS, median (IQR)3 (0--8)4 (1--14)3 (0--7)\<0.0001In-hospital mortality, *n* (%)936 (12.8)270 (37.7)666 (10.1)\<0.0001Severe hypocalcemia defined as ionized calcium less than 0.9 mmol/dL or 3.6 mg/dL within 48 h of admissionDisabled defined as limitations from injuries expected to last longer than 1 year*OSH* outside hospital, *SNF* skilled nursing facility, *rehab* rehabilitation facility, *ICU* intensive care unit, *LOS* length of stay

Multivariable analysis revealed that independent predictors of severe hypocalcemia were a penetrating mechanism (AOR 1.706), increased ISS (AOR 1.029), higher pRBC administration (AOR 1.343), and higher plasma administration (AOR 1.097) (Table [4](#Tab4){ref-type="table"}). Testing for interactions between variables revealed an interaction between pRBC and platelet and no other significant interactions were found. In this model, AUROC = 0.909 (95% CI = 0.897--0.921, *p* \< 0.0001). Independent predictors of mortality were penetrating mechanism (AOR 1.601), higher ISS (AOR 1.120), severe hypocalcemia (AOR 2.658), older age (AOR 1.040), platelet administration (AOR 1.389), and cryoprecipitate administration (AOR 1.058). In this model, AUROC = 0.888 (95% CI = 0.878--0.899, *p* = .005).Table 4Multivariable analysis regarding the association between variables and severe hypocalcemiaVariablesClinically significant severe hypocalcemiaAdjusted *p* valueAORCIPenetrating\<0.00011.7061.383, 2.103ISS\<0.00011.0291.021, 1.037PRBC prior to iCa nadir\<0.00011.3431.306, 1.381FFP prior to iCa nadir\<0.00011.0971.057, 1.14Plt prior to iCa nadir0.218PRBC^a^ Plt\<0.00010.9710.966, 0.977Cryo prior to iCa nadir0.126Age0.960Severe hypocalcemia defined as ionized calcium less than 0.9 mmol/dL or 3.6 mg/dL within 48 h of admission. Transfused blood products were maintained as continuous variables in the regression model.^a^Backward stepwise logistical regression performed with variables which were significant to *p* ≤ 0.2 in the univariate analysis. Significant variables were then included in the final logistical model using "enter" modeAUROC = 0.909 (95% CI = 0.897--0.921, *p* \< 0.0001)*ISS* injury severity score, *PRBC* packed red blood cells, *iCa* ionized calcium, *FFP* fresh Frozen plasma, *Plt* platelet, *Cryo* cryoprecipitate

Regression analysis identified a significantly higher risk of severe hypocalcemia at a combined pRBC + FFP administration of 4 units (AOR 18.706, AUC.897 (0.884--0.909) (Fig. [1](#Fig1){ref-type="fig"}). Covariates included ISS, penetrating trauma and platelet\*pRBC variables.Fig. 1Adjusted for covariates, the probability of developing severe hypocalcemia increases with transfusion of PRBC, FFP, or both. Covariates: ISS, penetrating mechanism, PRBC X Plt. Abbreviations: ISS-Injury Severity Score, PRBC-Packed Red Blood Cells, FFP-Fresh Frozen Plasma, Plt-Platelets. The gray bands are 95% confidence intervals

Discussion {#Sec4}
==========

Transfusion of pRBC was an independent predictors of severe hypocalcemia and ionized calcium decreased in a dose-dependent relationship with transfusion of pRBC. Total calcium is often used as a surrogate for ionized calcium, adjusting for hypoalbuminemia. There are several studies that suggest that the adjusted calcium formula does not adequately reflect ionized calcium concentrations and is not a reliable substitute in critically ill trauma patients \[[@CR2]--[@CR6]\] In our study, ionized calcium values were utilized exclusively. The incidence of hypocalcemia in the adult critically ill trauma population ranges widely from 55 to 97% with severe hypocalcemia rates of 6.2--71% depending on the definition of hypocalcemia used \[[@CR2], [@CR14]\]. Our lower hypocalcemia rate of 9.8% reflects the strict definition used as well as the inclusion of patients beyond the massively transfused patient population. To our knowledge, this is the largest study to date examining the relationship of blood administration to hypocalcemia.

Livingston et al. found no difference in hypocalcemia rates (41 vs 46%, *p* = 1.0) when comparing massively transfused (≥ 40 mL/kg) to non-massively transfused (\< 40 mL/kg) pediatric patients. Hypocalcemia was defined as either serum calcium \< 2.15 mmol/L (with correction by albumin when possible) or serum ionized calcium \< 0.9 mmol/L. In this smaller study, of the 13 patients that received massive transfusion, only eight received plasma and platelet in the first 24 h, which is different from the balanced resuscitation principles being utilized today \[[@CR15]\]. Giancarelli et al. noted a high incidence of hypocalcemia, defined as iCa \< 1.12 mmol or iCa \< 4.48 mg/dL, with 152 (97%) of 156 trauma patients receiving a massive transfusion demonstrating hypocalcemia. Severe hypocalcemia (iCa \< 0.9 mmol/L or iCa \< 3.6 mg/dL) was seen in 71% in this massive transfusion population \[[@CR14]\].

Previously, Kraft et al. \[[@CR16]\] established a relationship between the amount of pRBC administered and hypocalcemia. Patients with severe hypocalcemia had more units (34 vs 22) of pRBC transfused compared to patients without severe hypocalcemia in a retrospective analysis of 156 patients by Giancarelli et al. \[[@CR14]\]. ROC analysis in the massive transfusion patient cohort suggested that the transfusion of 15 units of total blood products was the best predictor for severe hypocalcemia. In our study, which expanded the population to all trauma patients that had an ionized calcium drawn, we found 4 units total of PRBC and FFP was associated with severe hypocalcemia. Since plasma can be administered rapidly due to its low viscosity, and has the highest concentration of citrate per unit volume of any blood product, ionized calcium is most likely to occur during FFP infusion \[[@CR17]\]. Furthermore, FFP and platelet contain \> 90% of the citrate contained in the original blood donation bag \[[@CR8]\]. Our results are consistent with a dose-response relationship between the volume of blood product administered and severity of hypocalcemia.

Poor clinical outcomes have been associated with hypocalcemia \[[@CR6], [@CR18]--[@CR23]\], and low admission ionized calcium is an independent predictor of multiple transfusions \[[@CR23]\]. Furthermore, in several large studies, severe hypocalcemia is independently associated with increased mortality. Inability to normalize ionized calcium by day 4 has been associated with a doubling of mortality \[[@CR2]\]. In this study, severe hypocalcemia was also found to be an independent predictor of mortality.

Previous studies suggest that calcium replacement may not improve calcium normalization or mortality \[[@CR2]\]. Calcium replacement protocols vary in the literature, and the role of replacement is uncertain. Cote et al. prospectively evaluated pediatric burn patients that required FFP infusion, and concluded that concurrent calcium replacement was potentially indicated to avoid dangerous fluctuations in ionized calcium. The study was originally undertaken after a number of cardiac arrests, and severe hypotensive episodes were witnessed in association with FFP infusion. Another pediatric study by Krishnan et al. examined calcium and magnesium supplementation during plasmapheresis and FFP transfusion in children with glomerulonephritis. The concentration of ionized calcium fell by similar proportions during FFP infusion in both the supplemented and standard cohorts but with higher measured values of absolute ionized calcium (0.92 mmol/L compared to 0.78 mmol/L) and decreased clinical symptoms of tetany (0% vs 29%) in the supplemented group \[[@CR24]\]. They subsequently protocolized routine calcium and magnesium supplementation and eliminated hypocalcemia symptoms from their population. An adult population of 84 patients that underwent 581 plasma exchanges for various autoimmune indications reported a lower incidence of tetany, which they partially attributed to their routine calcium supplementation as well as slower citrate infusion rates \[[@CR25]\]. Although we did not examine the role of calcium supplementation in our study, this is an area that warrants further investigation in the trauma population. In this study, administration of pRBC and FFP was independent predictors of hypocalcemia and a total of 4 units pRBC + FFP was associated with severe hypocalcemia. Furthermore, the predicted probability of severe hypocalcemia increased as the total pRBC + FFP administered increased.

Conclusion {#Sec5}
==========

Transfusion of pRBC and FFP are independent predictors of severe hypocalcemia, as the value of pRBC + FFP administered increase, the predicted probability of severe hypocalcemia also increases. A total of 4 units pRBC + FFP is associated with significantly higher risk of severe hypocalcemia.
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